A prospective randomised study of the optimal time for the administration of human chorionic gonadotropin (HCG) in women undergoing IVF in a gonadotropin releasing hormone (GnRH) antagonist cycle

Completed

• Conditions: Pregnancy and Childbirth: In vitro fertilisation (IVF); Pregnancy and Childbirth; Procreative management

• Registration Number: ISRCTN36416379
• Lead Sponsor: Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2003-09-12
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 0

Inclusion Criteria

1. Patients undergoing their first or second cycle of IVF or IVF/intracytoplasmic sperm injection (ICSI).
2. Age of partner 19-36 years.
3. Body mass index 20-30 kg/m2.
4. Serum follicle-stimulating hormone (FSH) concentration in normal range.

Exclusion Criteria

Does not match inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified